TOTAL CURRENT ASSETS TOTAL OTHER ASSETS TOTAL ASSETS Total assets (in Dollars) TOTAL CURRENT LIABILITIES TOTAL LONG TERM LIABILITIES TOTAL LIABILITIES Class of Stock [Axis] TOTAL STOCKHOLDERS’ EQUITY - CONTROLLING INTERESTS TOTAL STOCKHOLDERS’ EQUITY Balance Balance TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY Product and Service [Axis] Total cost of revenue GROSS LOSS Total cost of operations LOSS FROM OPERATIONS Total other income (expense), net LOSS BEFORE INCOME TAXES NET LOSS Net loss Balance (in Shares) Balance (in Shares) Equity Components [Axis] NET CASH USED IN OPERATING ACTIVITIES NET CASH PROVIDED BY INVESTING ACTIVITIES NET CASH PROVIDED BY FINANCING ACTIVITIES NET INCREASE IN CASH CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD Cash Crypto Asset [Axis] Balance as of the Closing Date Balance as of June 30, 2026 Digital assets, Fair value Balance, December 31, 2025 Balance, June 30, 2026 Balance, December 31, 2025 Balance, June 30, 2026 Long-Lived Asset, Class [Axis] Co-development Rights [Abstract] Transaction Type [Axis] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instrument [Axis] Measurement Input Type [Axis] Fair value Fair value Non-vested at beginning of period, Number of shares Non-vested at end of period, Number of shares Non-vested at beginning of period, weighted average grant date fair value Non-vested at end of period, Weighted average grant date fair value Award Type [Axis] Options outstanding as of beginning of period, Number of options (in Shares) Options outstanding as of end of period, Number of options (in Shares) Options outstanding as of beginning of period, Weighted average exercise price Options outstanding as of end of period, Weighted average exercise price Options outstanding as of beginning of period, Weighted average grant date fair value Options outstanding as of end of period, Weighted average grant date fair value Options outstanding as of beginning of period, Aggregate intrinsic value (in Dollars) Options outstanding as of end of period, Aggregate intrinsic value (in Dollars) Noncontrolling interests recognized at acquisition-date fair value Noncontrolling interests, June 30, 2026 Antidilutive Securities [Axis] Total Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Information, Former Legal or Registered Name Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Amendment Flag Document Fiscal Period Focus Current Fiscal Year End Date ASSETS CURRENT ASSETS Crypto assets Prepaid assets PROPERTY AND EQUIPMENT Mining equipment, net Net book value, June 30, 2026 OTHER ASSETS Co-development rights, net Investments Goodwill LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable Accrued expenses Other current liabilities LONG TERM LIABILITIES Derivative liability warrants COMMITMENTS AND CONTINGENCIES (NOTE 16) STOCKHOLDERS’ EQUITY Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 10,000 designated as Series A, zero shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized (in Shares) Preferred stock, shares authorized Preferred stock, shares issued (in Shares) Preferred stock, shares issued Preferred stock, shares outstanding (in Shares) Preferred stock, shares outstanding Common stock, $0.0001 par value, 150,000,000 shares authorized, 53,000,397 and 43,877,497 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized (in Shares) Common stock, shares authorized Common stock, shares issued (in Shares) Common stock,shares issued (in Shares) Common Stock, shares issued Common stock, shares outstanding (in Shares) Common stock,shares outstanding (in Shares) Common Stock, shares outstanding Additional paid-in capital Accumulated deficit TOTAL STOCKHOLDERS’ EQUITY - NONCONTROLLING INTERESTS Non-controlling interest REVENUE Total revenue COST OF REVENUE Cost of revenue Depreciation COST OF OPERATIONS Salary expense Professional services expense Amortization expense Amortization of co-development rights Impairment loss Stock based compensation expense General and administrative expenses Selling and marketing expense OTHER INCOME (EXPENSE) Other income, net NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss per share attributable to common stockholders - basic (in Dollars per share) Net loss per share – basic (in Dollars per share) Net loss per share attributable to common stockholders - diluted (in Dollars per share) Net loss per share – diluted (in Dollars per share) Weighted average number of common shares outstanding, basic (in Shares) Weighted-average shares outstanding – basic (in Shares) Weighted average number of common shares outstanding, diluted (in Shares) Weighted-average shares outstanding – diluted (in Shares) Business combination with Coeptis Therapeutics Holdings, Inc. Business combination with Coeptis Therapeutics Holdings, Inc. (in Shares) Spinout share distribution Spinout share distribution (in Shares) Spin-out shares (in Shares) Capital contribution - mining equipment Shares issued for standby equity purchase agreement (“SEPA”) (in Shares) Shares issued for standby equity purchase agreement (“SEPA”) Shares issued for services (in Shares) Shares of common stock Shares issued for services Shares issued for services, value (in Dollars) Shares issued for conversion of note payable and accrued interest Aggregate amount of convertible promissory note (in Dollars) Shares issued for conversion of note payable and accrued interest (in Shares) Shares of common stock upon conversion Stock based compensation OPERATING ACTIVITIES Adjustments to reconcile net loss to net cash used in operating activities Operating expenses paid with crypto assets Depreciation of mining equipment Impairment of co-development rights Stock based compensation Shares issued for non-employee services Shares issued for accrued interest Changes in assets and liabilities, net of effects of reverse acquisition: Accounts payable Accrued expenses INVESTING ACTIVITIES FINANCING ACTIVITIES Proceeds from shares issued for SEPA Proceeds from note payable SUPPLEMENTAL CASH FLOW DISCLOSURES Interest paid Taxes paid SUPPLEMENTAL NON-CASH DISCLOSURES Common stock issued as consideration in reverse acquisition Capital contribution of mining equipment Common stock issued for conversion of note payable and accrued interest Goodwill recognized in reverse acquisition Investment and Co-Development Rights recognized in reverse acquisition Financing Fee Payable assumed in reverse acquisition Noncontrolling interest recognized in reverse acquisition Milestone fee for license acquisition and included in accounts payable Loss on exchange of crypto assets Unrealized loss on crypto assets Interest expense Income tax benefit Income tax expense